Tabinda Hasan | Oncology and Precision Medicine | Women Researcher Award

Women Researcher Award

Tabinda Hasan

Princess Nourah bint Abdulrahman University, Saudi Arabia

Tabinda Hasan
Affiliation Princess Nourah bint Abdulrahman University
Country Saudi Arabia
Scopus ID 58492088000
Documents 40
Citations 199
h-index 8
Subject Area Oncology and Precision Medicine
Event International Research Awards on Oncology and Cancer Research
ORCID 0000-0001-6886-6220

Tabinda Hasan is presented as a researcher affiliated with Princess Nourah bint Abdulrahman University, Saudi Arabia, with a stated research focus in oncology and precision medicine. Her supplied bibliometric profile reports 40 documents, 199 citations, and an h-index of 8. These indicators provide a quantitative overview of her reported scholarly activity and citation performance. Her profile is considered in the context of the Women Researcher Award, recognizing research participation, academic contributions, and the advancement of scientific knowledge in relevant research disciplines. [1] [2]

Abstract

The Women Researcher Award recognizes the academic participation, research contributions, and scientific achievements of women researchers working across diverse scientific and medical disciplines. Tabinda Hasan, affiliated with Princess Nourah bint Abdulrahman University in Saudi Arabia, is presented for recognition in connection with the fields of oncology and precision medicine. Oncology and precision medicine are important areas of contemporary biomedical research, encompassing the investigation of cancer biology, disease characteristics, molecular mechanisms, diagnostic approaches, and individualized therapeutic strategies.  [1]

Keywords

Women Researcher Award; Tabinda Hasan; Oncology; Precision Medicine; Cancer Research; Biomedical Research; Academic Excellence; Women’s Scientific Contributions; Research Productivity; Citation Impact; Medical Research; Cancer Science; Personalized Healthcare; Scientific Recognition; Saudi Arabia.

Introduction

Scientific research plays an important role in improving healthcare systems, expanding medical knowledge, and addressing complex challenges in human health. Within this landscape, oncology and precision medicine have become significant areas of investigation because of their contributions to understanding cancer development, identifying disease-associated biomarkers, and exploring individualized treatment strategies.Tabinda Hasan’s submitted academic profile identifies Princess Nourah bint Abdulrahman University as her institutional affiliation and oncology and precision medicine as her stated subject area.  [1] [2]

Research Profile

Tabinda Hasan is identified in the supplied profile as an academic researcher affiliated with Princess Nourah bint Abdulrahman University, Saudi Arabia. Her stated subject area encompasses oncology and precision medicine, two closely related disciplines within contemporary biomedical and clinical research. Her academic profile is described using the bibliometric information provided for the award recognition submission.These indicators should be interpreted alongside publication quality, research relevance, authorship contributions, and the researcher’s broader academic activities. [1]

 Research Contributions

Oncology and precision medicine encompass a broad range of research activities directed toward understanding cancer development, disease progression, molecular characteristics, and treatment outcomes. Research contributions in these disciplines may involve laboratory investigations, clinical studies, diagnostic research, therapeutic evaluation, translational medicine, and interdisciplinary collaborations.The research interests identified in Tabinda Hasan’s submitted profile are relevant to several important areas of contemporary biomedical investigation. These include:

 Publications

The supplied publication information includes journal articles from 2013, 2016, and 2017 covering biomedical materials, clinical treatment procedures, laser-based pain treatment, nanocrystals, and dermatological applications. However, the contributor information in these records identifies Roman Šmucler and other researchers rather than Tabinda Hasan. Consequently, these records cannot be reliably attributed to Tabinda Hasan or presented as her verified publications based on the information provided.

 Research Impact

Research impact can be evaluated through several complementary indicators, including scholarly publications, citations, collaboration networks, research relevance, methodological contributions, and the potential application of scientific findings. In biomedical disciplines, the significance of research may also be reflected in its contribution to clinical understanding, diagnostic development, therapeutic investigation, and healthcare knowledge.

Award Suitability

The Women Researcher Award recognizes women scientists and academics whose research activities contribute to the development of scientific knowledge, academic excellence, and innovation across their respective disciplines. The award provides a platform for acknowledging research productivity, scholarly contributions, and participation in the international research community.

Conclusion

Tabinda Hasan is presented as a researcher affiliated with Princess Nourah bint Abdulrahman University, Saudi Arabia, with a stated subject specialization in oncology and precision medicine. Her submitted academic profile reports 40 research documents, 199 citations, and an h-index of 8. These indicators provide an overview of her reported scholarly activity and form part of the information considered for the Women Researcher Award.

References

1.Elsevier. (n.d.). Scopus author details: Tabinda Hasan, Author ID 58492088000. Scopus.

     https://www.scopus.com/authid/detail.uri?authorId=58492088000

2.ORCID. (n.d.). ORCID researcher identifier: 0000-0001-6886-6220. ORCID.

     https://orcid.org/0000-0001-6886-6220

4.Lippert, J., Šmucler, R., & Vlk, M. (2013). Fractional carbon dioxide laser improves nodular basal cell carcinoma treatment with photodynamic therapy     with methyl 5-aminolevulinate. Dermatologic Surgery.

     https://doi.org/10.1111/dsu.12242

5.Google Scholar. (n.d.). Researcher citation profile. Google Scholar.

     https://scholar.google.com/citations?user=GpQqXhMAAAAJ&hl=en

6. International Research Awards on Oncology and Cancer Research. (n.d.). Official Award Website. Pencis.

     https://oncology.pencis.com/

Hongyu li | Breast Cancer | Best Researcher Award

Hongyu li | Breast Cancer | Best Researcher Award

Xinjiang medical university | China

AUTHOR PROFILE

SCOPUS

🎓EARLY ACADEMIC PURSUITS 

Assoc. Prof. Dr. Hongyu Li embarked on her academic journey at Xinjiang Medical University, where she earned her Doctor of Medicine degree and subsequently completed a Ph.D. in 2021. Her formative years were marked by rigorous academic training and an early interest in the oncology of breast diseases, which laid the foundation for her future specialization in breast cancer metastasis research.

👩‍🏢PROFESSIONAL ENDEAVORS 

Currently serving as an Associate Professor, Associate Chief Physician, and Doctor of Medicine at the Department of Breast Internal Medicine, Xinjiang Medical University Affiliated Tumor Hospital, Dr. Li brings over a decade of clinical expertise to the field. Her clinical focus is on the early detection, diagnosis, and management of breast cancer. She has been honored with prestigious awards including the “Tianchi Talent” Youth Doctor Award (2022), the Outstanding Postdoctoral Special Funding (2023), and was selected for the “789 Talent” Training Program (2024), cementing her reputation as a High-Level Talent and Outstanding Young Physician.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON BREAST CANCER 

Dr. Li’s scientific inquiry is anchored in understanding the molecular mechanisms of breast cancer metastasis, with a specific focus on breast cancer brain metastasis (BCBM)—a critical and poorly understood manifestation associated with poor prognosis. Her translational research bridges clinical challenges and bench-side investigations, aiming to identify novel biomarkers and potential therapeutic targets for BCBM.

She adopts an integrative approach that translates clinical observations into mechanistic questions, enhancing the effectiveness of future treatments and diagnostic strategies for late-stage breast cancer.

📚IMPACT AND INFLUENCE 

Dr. Li’s work is contributing to shaping the clinical paradigms in breast cancer care within the Xinjiang region and beyond. Her research is improving understanding of metastatic processes, especially in underrepresented ethnic populations. She is also involved in institutional collaborations and has served in editorial capacities, reinforcing her influence in both academic and clinical oncology spheres.

💪LEGACY AND FUTURE CONTRIBUTIONS 

Looking forward, Dr. Li aims to establish a dedicated translational research unit focused on metastatic breast cancer, particularly BCBM. She is committed to mentoring young researchers and expanding interdisciplinary collaborations that bridge molecular oncology with precision medicine. Her ultimate goal is to redefine treatment algorithms and enhance survival outcomes for patients with advanced-stage breast cancer.

🌍CONCLUSION 

Assoc. Prof. Dr. Hongyu Li stands as a beacon of translational oncology, seamlessly integrating clinical care with cutting-edge research. Her relentless pursuit of knowledge, commitment to public health, and strategic focus on a critically unmet need in oncology make her a deserving nominee for the Best Researcher Award.

 

📊🔬NOTABLE PUBLICATION:

Title: GRB2 promotes brain metastasis in HER2-positive breast cancer by regulating the Ras/MAPK pathway

Authors: Hongyu Li, Yalin Zhang, Xiao Han, Bingyu Li, Dan Liu, Gang Sun

Journal: Scientific Reports (Nature Publishing Group)

Year: 2025

Jianqiang Wu | Melanoma | Best Researcher Award

Mr. Jianqiang Wu | Melanoma | Best Researcher Award

Guangzhou Medical University | China

AUTHOR PROFILE

ORCID ID

🏥MR. JIANQIANG WU: ACADEMIC AND PROFESSIONAL PROFILE

🎓EARLY ACADEMIC PURSUITS

Mr. Jianqiang Wu pursued his medical education with a focus on dermatology, establishing a strong foundation in medical sciences. His early academic years were marked by rigorous training, research involvement, and a keen interest in skin-related disorders, particularly melanoma.

🩺PROFESSIONAL ENDEAVORS

Currently serving at the Department of Dermatology, the Affiliated Panyu Central Hospital, Guangzhou Medical University, China, Mr. Wu has been an integral part of the institution’s dermatological research and clinical services. His dedication to patient care and medical research has significantly contributed to advancements in dermatology.

🔬CONTRIBUTIONS AND RESEARCH FOCUS

Mr. Wu has dedicated a substantial part of his career to the study and treatment of melanoma, a serious form of skin cancer. His research focuses on early diagnosis, innovative treatments, and improving therapeutic outcomes for melanoma patients. He has played a pivotal role in developing targeted therapies and exploring the genetic and molecular mechanisms underlying melanoma progression.

🌍IMPACT AND INFLUENCE

Through his research and clinical practice, Mr. Wu has influenced the field of dermatology, particularly in the early detection and treatment of melanoma. His work has led to improved diagnostic techniques and treatment protocols, benefiting patients in China and beyond. His contributions to medical education have also guided the next generation of dermatologists.

📚ACADEMIC CITATIONS

Mr. Wu’s research findings have been widely cited in peer-reviewed journals, reflecting their significance in the scientific community. His publications contribute to a growing body of knowledge in dermatology, particularly in melanoma treatment strategies.

🏆LEGACY AND FUTURE CONTRIBUTIONS

With a strong track record in clinical and academic dermatology, Mr. Wu’s legacy is marked by his commitment to advancing melanoma research. His future endeavors may include further innovation in personalized medicine, novel therapeutic approaches, and international collaborations to combat skin cancer more effectively.

💊OTHER IMPORTANT TOPICS

  • Collaborations: Engages in interdisciplinary collaborations with oncologists, geneticists, and immunologists to enhance melanoma treatment.
  • Mentorship: Actively mentors young dermatologists, contributing to the academic and professional growth of upcoming medical professionals.
  • Public Health Initiatives: Involved in skin cancer awareness campaigns, promoting early detection and prevention measures in the community.
  • Technological Integration: Advocates for the use of AI and advanced imaging technologies in dermatological diagnostics.

🧬CONCLUSION

Mr. Jianqiang Wu has made remarkable contributions to the field of dermatology, particularly in melanoma research and treatment. His dedication to patient care, innovative research, and academic mentorship ensures that his impact will be felt for years to come. As he continues to push the boundaries of dermatological science, his work stands as a testament to his unwavering commitment to medical advancement and improved patient outcomes.

 

📊🔬NOTABLE PUBLICATION:
    1. Title: CRIP1 inhibits cutaneous melanoma progression through TFAM-mediated mitochondrial biogenesis
      Authors: Jianqiang Wu, Lixia Chen, Peijun Wen.
      Journal: Scientific Reports
      Year: 2025